Research ArticleBasic Science Investigations
In Vivo and In Vitro Characterization of a Novel MAO-B Inhibitor Radioligand, 18F-Labeled Deuterated Fluorodeprenyl
Sangram Nag, Patrik Fazio, Lutz Lehmann, Georg Kettschau, Tobias Heinrich, Andrea Thiele, Marie Svedberg, Nahid Amini, Samira Leesch, Ana M. Catafau, Jonas Hannestad, Andrea Varrone and Christer Halldin
Journal of Nuclear Medicine February 2016, 57 (2) 315-320; DOI: https://doi.org/10.2967/jnumed.115.161083
Sangram Nag
1Centre for Psychiatric Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
Patrik Fazio
1Centre for Psychiatric Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
Lutz Lehmann
2Bayer HealthCare AG, Global Drug Discovery, Berlin, Germany
Georg Kettschau
2Bayer HealthCare AG, Global Drug Discovery, Berlin, Germany
Tobias Heinrich
2Bayer HealthCare AG, Global Drug Discovery, Berlin, Germany
Andrea Thiele
2Bayer HealthCare AG, Global Drug Discovery, Berlin, Germany
Marie Svedberg
1Centre for Psychiatric Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
Nahid Amini
1Centre for Psychiatric Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
Samira Leesch
3Piramal Imaging GmbH, Berlin, Germany; and
Ana M. Catafau
3Piramal Imaging GmbH, Berlin, Germany; and
Jonas Hannestad
4UCB Pharma, Braine-l’Alleud, Belgium
Andrea Varrone
1Centre for Psychiatric Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
Christer Halldin
1Centre for Psychiatric Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 57, Issue 2
February 1, 2016
In Vivo and In Vitro Characterization of a Novel MAO-B Inhibitor Radioligand, 18F-Labeled Deuterated Fluorodeprenyl
Sangram Nag, Patrik Fazio, Lutz Lehmann, Georg Kettschau, Tobias Heinrich, Andrea Thiele, Marie Svedberg, Nahid Amini, Samira Leesch, Ana M. Catafau, Jonas Hannestad, Andrea Varrone, Christer Halldin
Journal of Nuclear Medicine Feb 2016, 57 (2) 315-320; DOI: 10.2967/jnumed.115.161083
In Vivo and In Vitro Characterization of a Novel MAO-B Inhibitor Radioligand, 18F-Labeled Deuterated Fluorodeprenyl
Sangram Nag, Patrik Fazio, Lutz Lehmann, Georg Kettschau, Tobias Heinrich, Andrea Thiele, Marie Svedberg, Nahid Amini, Samira Leesch, Ana M. Catafau, Jonas Hannestad, Andrea Varrone, Christer Halldin
Journal of Nuclear Medicine Feb 2016, 57 (2) 315-320; DOI: 10.2967/jnumed.115.161083